Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
Biotech
Inflammation-focused Upstream to join trickle of biotech IPOs
The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an intention to go public.
James Waldron
Sep 19, 2024 4:50am
AstraZeneca IL-33 drug fails to improve COPD breathing in ph. 2
Sep 8, 2024 9:45am
Pneumagen's flu antiviral stands up to human challenge study
Oct 2, 2023 4:00am
Study sees COPD patients' breathing boosted by hands-free device
Mar 10, 2023 4:30pm
AstraZeneca beefs up COPD pipeline with $400M biobuck bet
Nov 28, 2022 6:25am
Boehringer's rewards app boosts COPD medication adherence
Aug 10, 2022 12:03pm
